Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-31

FDA Approved: LUMASON — Supplemental Application (BRACCO DIAGNOSTICS INC)

View source ↗

Summary

FDA approves a supplemental application for Lumason (sulfur hexafluoride) from Bracco Diagnostics to expand the approved indications for ultrasound contrast ima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMASON (sulfur hexafluoride lipid microspheres)

Snippet

SUPPL AP for LUMASON (SULFUR HEXAFLUORIDE)